Estrogen-secreting adrenocortical carcinoma
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Adrenocortical carcinoma is a rare type of endocrine malignancy with an annual incidence of approximately 1–2 cases per million. The majority of these tumors secrete cortisol, and a few secrete aldosterone or androgen. Estrogen-secreting adrenocortical carcinomas are extremely rare, irrespective of the secretion status of other adrenocortical hormones. Here, we report the case of a 53-year-old man with a cortisol and estrogen-secreting adrenocortical carcinoma. The patient presented with gynecomastia and abdominal discomfort. Radiological assessment revealed a tumor measuring 21×15.3×12 cm localized to the retroperitoneum. A hormonal evaluation revealed increased levels of estradiol, dehydroepiandrosterone sulfate, and cortisol. The patient underwent a right adrenalectomy, and the pathological examination revealed an adrenocortical carcinoma with a Weiss’ score of 6. After surgery, he was treated with adjuvant radiotherapy. Twenty-one months after treatment, the patient remains alive with no evidence of recurrence.
Abstract
Adrenocortical carcinoma is a rare type of endocrine malignancy with an annual incidence of approximately 1–2 cases per million. The majority of these tumors secrete cortisol, and a few secrete aldosterone or androgen. Estrogen-secreting adrenocortical carcinomas are extremely rare, irrespective of the secretion status of other adrenocortical hormones. Here, we report the case of a 53-year-old man with a cortisol and estrogen-secreting adrenocortical carcinoma. The patient presented with gynecomastia and abdominal discomfort. Radiological assessment revealed a tumor measuring 21×15.3×12 cm localized to the retroperitoneum. A hormonal evaluation revealed increased levels of estradiol, dehydroepiandrosterone sulfate, and cortisol. The patient underwent a right adrenalectomy, and the pathological examination revealed an adrenocortical carcinoma with a Weiss’ score of 6. After surgery, he was treated with adjuvant radiotherapy. Twenty-one months after treatment, the patient remains alive with no evidence of recurrence.
참고문헌 (20)
- Wajchenberg BL, "Adrenocortical carcinoma: clinical and laboratory observations", Cancer, 88, pp.711~736 (2000)
- Dackiw AP, "Adrenal cortical carcinoma", World J Surg, 25, pp.914~926 (2001)
- Allolio B, "Management of adrenocortical carcinoma", Clin Endocrinol (Oxf), 60, pp.273~287 (2004)
- Libe R, "Adrenocortical cancer: pathophysiology and clinical management", Endocr Relat Cancer, 14, pp.13~28 (2007)
- Moreno S, "Feminizing adreno-cortical carcinomas in male adults. A dire prognosis. Three cases in a series of 801 adrenalectomies and review of the literature", Ann Endocrinol (Paris), 67, pp.32~38 (2006)
- Zayed A, "Feminization as a result of both peripheral conversion of androgens and direct estrogen production from an adrenocortical carcinoma", J Endocrinol Invest, 17, pp.275~278 (1994)
- Abiven G, "Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients", J Clin Endocrinol Metab, 91, pp.2650~2655 (2006)
- Lanigan D, "A feminizing adrenocortical carcinoma presenting with gynaecomastia", Postgrad Med J, 69, pp.481~483 (1993)
- Shen WT, "From incidentaloma to adrenocortical carcinoma: the surgical management of adrenal tumors", J Surg Oncol, 89, pp.186~192 (2005)
- Advani A, "Adult-onset hypogonadotropic hypogonadism caused by aberrant expression of aromatase in an adrenocortical adenocarcinoma", Endocr J, 57, pp.651~656 (2010)
- Gupta N, "Abdominal wall metastasis in scar after open resection of an adrenocortical carcinoma", Clin Pract, 2, pp.e9~ (2012)
- Weiss LM, "Pathologic features of prognostic significance in adrenocortical carcinoma", Am J Surg Pathol, 13, pp.202~206 (1989)
- Schulick RD, "Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma", Ann Surg Oncol, 6, pp.719~726 (1999)
- Bilimoria KY, "Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors", Cancer, 113, pp.3130~3136 (2008)
- Patalano A, "Adrenocortical cancer treatment", Horm Res, 71(Suppl 1), pp.99~104 (2009)
- Berruti A, "Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up", Ann Oncol, 23(Suppl 7), pp.vii131~vii138 (2012)
- Lafemina J, "Adrenocortical carcinoma: past, present, and future", J Surg Oncol, 106, pp.586~594 (2012)
- Kirschner LS, "The next generation of therapies for adrenocortical cancers", Trends Endocrinol Metab, 23, pp.343~350 (2012)
- Nigri G, "Meta-analysis of trials comparing laparoscopic transperitoneal and retroperitoneal adrenalectomy", Surgery, 153, pp.111~119 (2013)
- Fassnacht M, "Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma", J Clin Endocrinol Metab, 91, pp.4501~4504 (2006)